|
Chronic ischemic heart disease
Citations 81-90 of 1248 total displayed.
|
Past content
(since Jan 1999):
|
- Clinician Update
Coronary Stents and Chronic Anticoagulation
- Angelos Sourgounis, Janusz Lipiecki, Ted S. Lo, and Martial Hamon
Circulation 2009;119:1682-1688, doi:10.1161/CIRCULATIONAHA.108.834861
[Full text]
- Images in Cardiovascular Medicine
Multiple Coronary Stenosis in Infantile Moyamoya Disease
- Tomoaki Murakami, Michihiko Ueno, Atsuhito Takeda, Satoshi Yakuwa, and Satoshi Kuroda
Circulation 2009;119:1689, doi:10.1161/CIRCULATIONAHA.108.827782
[Full text]
- Articles
Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India
- Rohina Joshi, Clara K. Chow, P. Krishnam Raju, Rama Raju, K. Srinath Reddy, Stephen MacMahon, Alan D. Lopez, and Bruce Neal
Circulation published March 30, 2009, doi:10.1161/CIRCULATIONAHA.108.819201
[Abstract]
- Articles
Molecular Magnetic Resonance Imaging of Myocardial Perfusion With EP-3600, a Collagen-Specific Contrast Agent. Initial Feasibility Study in a Swine Model
- Elmar Spuentrup, Karl M. Ruhl, Rene M. Botnar, Andrea J. Wiethoff, Alexandra Buhl, Vincent Jacques, Matthew T. Greenfield, Gabriele A. Krombach, Rolf W. Günther, Mark G. Vangel, and Peter Caravan
Circulation published March 23, 2009, doi:10.1161/CIRCULATIONAHA.108.826388
[Abstract]
- Articles
Effects of Different Types of Exercise Training Followed by Detraining on Endothelium-Dependent Dilation in Patients With Recent Myocardial Infarction
- M. Vona, G. M. Codeluppi, T. Iannino, E. Ferrari, J. Bogousslavsky, and L. K. von Segesser
Circulation published March 16, 2009, doi:10.1161/CIRCULATIONAHA.108.821736
[Abstract]
- Health Services and Outcomes Research
Temporal Changes in Coronary Revascularization Procedures, Outcomes, and Costs in the Bare-Metal Stent and Drug-Eluting Stent Eras: Results From the US Medicare Program
- Jason Ryan, Walter Linde-Zwirble, Luella Engelhart, Liesl Cooper, and David J. Cohen
Circulation 2009;119:952-961; published online before print as doi:10.1161/CIRCULATIONAHA.108.781138
[Abstract]
[Full text]
- Controversies in Cardiovascular Medicine
Surgery, Not Percutaneous Revascularization, Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis
- Craig R. Smith
Circulation 2009;119:1013-1020, doi:10.1161/CIRCULATIONAHA.108.792267
[Full text]
- Controversies in Cardiovascular Medicine
Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis
- Paul S. Teirstein
Circulation 2009;119:1021-1033, doi:10.1161/CIRCULATIONAHA.107.759712
[Full text]
- Interventional Cardiology
Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents: Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III Trial
- Gregg W. Stone, Mark Midei, William Newman, Mark Sanz, James B. Hermiller, Jerome Williams, Naim Farhat, Ronald Caputo, Nicholas Xenopoulos, Robert Applegate, Paul Gordon, Roseann M. White, Krishnankutty Sudhir, Donald E. Cutlip, John L. Petersen for the SPIRIT III Investigators
Circulation 2009;119:680-686; published online before print as doi:10.1161/CIRCULATIONAHA.108.803528
[Abstract]
[Full text]
- Articles
Temporal Changes in Coronary Revascularization Procedures, Outcomes, and Costs in the Bare-Metal Stent and Drug-Eluting Stent Eras. Results From the US Medicare Program
- Jason Ryan, Walter Linde-Zwirble, Luella Engelhart, Liesl Cooper, and David J. Cohen
Circulation published February 9, 2009, doi:10.1161/CIRCULATIONAHA.108.781138
[Abstract]
|
|
